Physician profile
Mark Thomas Rose
NPI 1801212428
$52,577.51
in general payments reported to CMS, 2019-2025
14 companies · $229 in 2025
The $229 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $9,543 · 2021: $1,499 · 2022: $2,014 · 2023: $2,546 · 2024: $2,100 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,555 · Travel and Lodging: $2,223 · Education: $96.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,555.42 |
| Travel and Lodging | $2,223.34 |
| Education | $96.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $26,028.54 | 2019-2024 | |
| Djo, LLC | $5,833.32 | 2019-2020 | |
| Fortis Surgical, LLC | $5,665.22 | 2019 | |
| Linvatec Corporation | $5,000.00 | 2020 | |
| Smith+Nephew, INC. | $4,643.21 | 2019-2024 | Aetos Shoulder System, Bioinductive Implant With Arthroscopic Delivery System - Medium, Healicoil |
| Zimmer Biomet Holdings, INC. | $2,287.01 | 2022-2024 | Rosa, Tapestry, Identity |
| Rock Medical Orthopedics, INC. | $1,698.09 | 2020-2024 | |
| Stryker Corporation | $1,043.59 | 2020-2025 | Mako, Triathlon, T2 Alpha |
| Vericel Corporation | $211.94 | 2019-2025 | Maci |
| Depuy Synthes Sales INC. | $97.12 | 2020-2025 | Monovisc |
| Sumitomo Pharma America, INC. | $23.94 | 2025 | Gemtesa |
| Teva Pharmaceuticals USA, INC. | $17.52 | 2022 | |
| Allergan, INC. | $16.66 | 2019 | |
| Pfizer INC. | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.